The Latin America synbiotic products market Valued at USD xx million in 2022 and is anticipated reach about USD xx million by 2027
Synbiotic foods are food products that contain a combination of prebiotics and probiotics in synergy that stimulate the growth and survival of bacteria in the intestine. These bacteria are found mainly in the intestine and colon of a human body in the gastrointestinal tract. Synbiotic foods help improve proper bowel function, which cannot be obtained in sufficient quantity with a regular diet. Synbiotics improve intestinal health and modulate host bacteria to improve gastrointestinal functions. They play an important role in preventing osteoporosis, relieving lactose intolerance and other common conditions. Synbiotics promote heart health and ease inflammation while reducing the risk of cardiovascular or carcinogenic disorders.
Recent Developments:
In 2019, Sabinsa Corporation launched a synbiotic products -LactoSporin®, which is a new probiotic metabolite for skin and hair.
In March 2018, NUtech Ventures has entered into an alliance with U.S.-based probiotic specialist Viva 5 Corporation, which contains a special human strain of Bifidobacterium adolescentis with a prudently selected galactooligosaccharide (GOS) prebiotic and is distributed as a capsule, tablet, stick bar, and powder.
In December 2010, Pfizer completed the purchase of Synbiotics Corporation for a market value of about US$ 20 million.
The growing awareness of urban consumers about health has led to increased consumption of functional foods and beverages, thus stimulating the market for synbiotic products in Latin America. The growing health problems of the growing population have increased the demand for functional foods. Additionally, eating synbiotic products offers several benefits, including improving digestive health, improving immune function, reducing inflammation, and minimizing the risk of cardiovascular ailments. The growth of the middle-class population and rapid urbanization, as well as the growing awareness of the health benefits of synbiotics, is the main factor that should stimulate the regional market during the outlook period. Synbiotic products are increasingly accepted across the area, due to the growing health problems of the population. However, the expenses related to the synbiotic products can limit overall sales in this business, which, in turn, can hinder growth of the LATAM synbiotic products market. The surge in need for functional foods and beverages is also supplementing the growth of the synbiotic products industry. Furthermore, R&D continues in this industry and the strategic initiatives undertaken by the main actors should boost the synbiotic product's market during the evaluated years. However, the high price of synbiotics and their ignorance may limit the growth of the LATAM synbiotic products market in the future. However, the increased loss of aquaculture species should increase the demand for animal feed, fueling the growth of the synbiotic product's market.
Segmentation by Type
Dietary Supplements
Drinks
Sandwiches
Dairy and frozen desserts
Bakery and cake shop
Others (include dry food, feed, fermented meat, etc.)
The dairy product segment has the most substantial share in the Latin America synbiotic products market. However, dietary supplements are found to have more demand and are supposed to overgrow over the anticipated period.
Segmentation by packaging material:
Paper
Plastic
Cup
Metal
Segmentation by application:
Medication
Animal food
Food and Beverages
Segmentation by Distribution Channel
Store based
Non-store based
Mexico
Brazil
Peru
Chile
Latin America is one of the key emerging regions, which will generate significant opportunities in the synbiotic products business over the calculated period due to increased consumer awareness of food and beverages, pharmaceuticals, pet food and personal care products. This is also expected to support overall business growth in the future.
Seed Health, Inc
Sabinsa Corporation
Biomin America Inc
Yakult Honsha Co., Ltd
H&H Group
The Kellogg Company
Danone S.A
General Mills, Inc. (US)
Pfizer Inc. (US)
Daflorn Ltd. (Bulgaria)
United Naturals
Probiotical S.p.A.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1200
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region